ADSTILADRIN Early Utilization and Outcomes in the Real World Setting
Stopped early
Conditions studied: Bladder Cancer
In brief
Multi-center, prospective non-interventional study to collect data on the early use of Adstiladrin in the US and Israel. Data will be collected from patients and prescribing physicians in a real-world setting
Key facts
- Study ID
- NCT06026332
- Run by
- Ferring Pharmaceuticals
- People needed
- 202
- Starts
- 2023-09-15
- Expected to finish
- 2026-01-15
- Last updated by the study team
- 2026-02-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Prescribed and scheduled treatment with ADSTILADRIN per physician discretion or received the first instillation of ADSTILADRIN per physician discretion after 5 September 2023 but prior to site activation
- Signed and dated ICF.
- Age 18 years or older at day ICF is signed.
You may not qualify if…
- Currently enrolled in a clinical trial.
- Participants who have previously been treated with ADSTILADRIN in the context of a clinical trial
- Participant is pregnant or breastfeeding.
Where it is running
- Banner Health MD Anderson Cancer Center — Gilbert, Arizona, United States
- Mayo Clinic Arizona — Phoenix, Arizona, United States
- Arkansas Urology, North Little Rock — Little Rock, Arkansas, United States
- Urology Associates of Central California — Fresno, California, United States
- USC Norris Comprehensive Cancer Center — Los Angeles, California, United States
- UF Health Surgical Specialists - Gainesville — Gainesville, Florida, United States
- Mayo Clinic — Jacksonville, Florida, United States
- Mount Sinai Medical Center — Miami Beach, Florida, United States
- Florida Urology Partners — Riverview, Florida, United States
- Florida Urology Partners — St. Petersburg, Florida, United States
- Florida Urology Partners — Tampa, Florida, United States
- Florida Urology Partners — Tampa, Florida, United States
- Emory University — Atlanta, Georgia, United States
- Georgia Urology — Atlanta, Georgia, United States
- UROLOGY OF INDIANA - GREENWOOD FQ: Urology of Indiana US Uro Partners — Greenwood, Indiana, United States
- First Urology Research (Jeffersonville) — Jeffersonville, Indiana, United States
- Wichita Urology - Wichita Webb — Wichita, Kansas, United States
- Johns Hopkins Hospital — Baltimore, Maryland, United States
- Mayo Clinic - Rochester Minnesota — Rochester, Minnesota, United States
- Minnesota Urology — Woodbury, Minnesota, United States
- The Urology Center, PC — Omaha, Nebraska, United States
- AMP UROLOGY, Syracuse - US Urology Partners — Syracuse, New York, United States
- SUNY Upstate Medical University Syracuse — Syracuse, New York, United States
- Montefiore Medical Center (Bronx2) — The Bronx, New York, United States
- Central OH Urology Group - US Urology Partners — Gahanna, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.